Gromek Kamila, Drumond Nélio, Simas Paula
Int J Risk Saf Med. 2015;27(2):55-65. doi: 10.3233/JRS-150643.
The importance of herbal remedies in pharmacovigilance systems is becoming one of the primary tasks, due to the constantly ascending potential of herbal products and herbal medicines worldwide. Nowadays, the drug development is focused on finding new active compounds or combinations, but costs are simultaneously growing, which makes herbal medicines an attractive, harmless and cheaper alternative to synthetic drugs.Like all drugs, herbal are not free of risk and many studies suggest for potential adverse reactions and interactions. Available statistics show that some herbal products, used in traditional medication for generations, may possess carcinogenic, hepatotoxic, cardiotoxic and other severe actions. Evaluation of the safety should include at least in vitro and in vivo genotoxicity assays, long-term rodent carcinogenicity tests (for drugs intended to be continuously used for >3 months or intermittently for >6 months), reproductive and developmental toxicity studies in some cases and examination of the effects on drug-metabolizing enzymes. Drug safety of herbal medicines should be developed, focusing on specific groups of patients.
由于全球范围内草药产品和草药的潜在影响力持续上升,草药疗法在药物警戒系统中的重要性正成为主要任务之一。如今,药物研发聚焦于寻找新的活性化合物或化合物组合,但成本也在同时增加,这使得草药成为合成药物颇具吸引力、无害且更便宜的替代品。与所有药物一样,草药并非没有风险,许多研究表明其存在潜在的不良反应和相互作用。现有统计数据显示,一些世代用于传统药物治疗的草药产品可能具有致癌、肝毒性、心脏毒性及其他严重作用。安全性评估应至少包括体外和体内遗传毒性试验、长期啮齿动物致癌性试验(针对打算连续使用超过3个月或间歇性使用超过6个月的药物),某些情况下还需进行生殖和发育毒性研究以及对药物代谢酶影响的检查。应针对特定患者群体开展草药的药物安全性研究。